LINC01094, also called CTEPHA1, was previously linked to chronic thromboembolic pulmonary hypertension (28) and has since been implicated in the malignant phenotypes of kidney cancer, glioma, and ovarian cancer (29–33). Here, LINC01094 is linked to central nervous system cancer.